David Hallal
2021
In 2021, David Hallal earned a total compensation of $16.8M as Chairman and Former Chief Executive Office at Allovir, a 10% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $81,562 |
---|---|
Option Awards | $9,781,229 |
Salary | $219,000 |
Stock Awards | $6,620,880 |
Other | $95,042 |
Total | $16,797,713 |
Hallal received $9.8M in option awards, accounting for 58% of the total pay in 2021.
Hallal also received $81.6K in non-equity incentive plan, $219K in salary, $6.6M in stock awards and $95K in other compensation.
Rankings
In 2021, David Hallal's compensation ranked 439th out of 12,415 executives tracked by ExecPay. In other words, Hallal earned more than 96.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 439 out of 12,415 | 97th |
Division Manufacturing | 139 out of 5,508 | 98th |
Major group Chemicals And Allied Products | 43 out of 2,378 | 98th |
Industry group Drugs | 38 out of 2,099 | 98th |
Industry Biological Products, Except Diagnostic Substances | 16 out of 449 | 96th |
Source: SEC filing on April 6, 2022.
Hallal's colleagues
We found four more compensation records of executives who worked with David Hallal at Allovir in 2021.